Speak directly to the analyst to clarify any post sales queries you may have.
The publisher has been monitoring the periodontal therapeutics market and it is poised to grow by $ 120.80 mn during 2021-2025, progressing at a CAGR of over 6% during the forecast period. The report on the periodontal therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of periodontal diseases, changing lifestyles, and comorbidities associated with periodontal diseases.
The periodontal therapeutics market analysis includes the product segment and geographic landscape.
The periodontal therapeutics market is segmented as below:
By Product
- Local antibiotics
- Systemic antibiotics
By Geographical Landscape
- North America
- Europe
- Asia
- ROW
This study identifies the growing geriatric population as one of the prime reasons driving the periodontal therapeutics market growth during the next few years. Also, the advent of biologics and rising government initiatives will lead to sizable demand in the market.
The report on periodontal therapeutics market covers the following areas:
- Periodontal therapeutics market sizing
- Periodontal therapeutics market forecast
- Periodontal therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading periodontal therapeutics market vendors that include 3M Co., Bausch Health Companies Inc., Cadila Healthcare Ltd., Den-Mat Holdings LLC, Dexcel Pharma Technologies Ltd., KAKEN PHARMACEUTICAL CO. LTD., Pfizer Inc., Straumann Holding AG, Sunstar Suisse SA, and Teva Pharmaceutical Industries Ltd. Also, the periodontal therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary- Market overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2020
- Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
- Five forces summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Product
- Market segments
- Comparison by Product
- Local antibiotics - Market size and forecast 2020-2025
- Systemic antibiotics - Market size and forecast 2020-2025
- Market opportunity by Product
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2020-2025
- Europe - Market size and forecast 2020-2025
- Asia - Market size and forecast 2020-2025
- ROW - Market size and forecast 2020-2025
- Key leading countries
- Market opportunity By Geographical Landscape
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Competitive scenario
- Vendor landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- 3M Co.
- Bausch Health Companies Inc.
- Cadila Healthcare Ltd.
- Den-Mat Holdings LLC
- Dexcel Pharma Technologies Ltd.
- KAKEN PHARMACEUTICAL CO. LTD.
- Pfizer Inc.
- Straumann Holding AG
- Sunstar Suisse SA
- Teva Pharmaceutical Industries Ltd.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
List of Exhibits
- Key Finding 1
- Key Finding 2
- Key Finding 3
- Key Finding 5
- Key Finding 6
- Key Finding 7
- Key Finding 8
- Parent market
- Market characteristics
- Offerings of vendors included in the market definition
- Market segments
- Global - Market size and forecast 2020 - 2025 ($ million)
- Global market: Year-over-year growth 2020 - 2025 (%)
- Five forces analysis 2020 & 2025
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition - Five forces 2020
- Product - Market share 2020-2025 (%)
- Comparison by Product
- Local antibiotics - Market size and forecast 2020-2025 ($ million)
- Local antibiotics - Year-over-year growth 2020-2025 (%)
- Systemic antibiotics - Market size and forecast 2020-2025 ($ million)
- Systemic antibiotics - Year-over-year growth 2020-2025 (%)
- Market opportunity by Product
- Customer landscape
- Market share By Geographical Landscape 2020-2025 (%)
- Geographic comparison
- North America - Market size and forecast 2020-2025 ($ million)
- North America - Year-over-year growth 2020-2025 (%)
- Europe - Market size and forecast 2020-2025 ($ million)
- Europe - Year-over-year growth 2020-2025 (%)
- Asia - Market size and forecast 2020-2025 ($ million)
- Asia - Year-over-year growth 2020-2025 (%)
- ROW - Market size and forecast 2020-2025 ($ million)
- ROW - Year-over-year growth 2020-2025 (%)
- Key leading countries
- Market opportunity By Geographical Landscape ($ million)
- Impact of drivers and challenges
- Vendor landscape
- Landscape disruption
- Industry risks
- Vendors covered
- Market positioning of vendors
- 3M Co. - Overview
- 3M Co. - Business segments
- 3M Co. - Key offerings
- 3M Co. - Key customers
- 3M Co. - Segment focus
- Bausch Health Companies Inc. - Overview
- Bausch Health Companies Inc. - Business segments
- Bausch Health Companies Inc. - Key offerings
- Bausch Health Companies Inc. - Key customers
- Bausch Health Companies Inc. - Segment focus
- Cadila Healthcare Ltd. - Overview
- Cadila Healthcare Ltd. - Product and service
- Cadila Healthcare Ltd. - Key offerings
- Cadila Healthcare Ltd. - Key customers
- Cadila Healthcare Ltd. - Segment focus
- Den-Mat Holdings LLC - Overview
- Den-Mat Holdings LLC - Product and service
- Den-Mat Holdings LLC - Key offerings
- Den-Mat Holdings LLC - Key customers
- Den-Mat Holdings LLC - Segment focus
- Dexcel Pharma Technologies Ltd. - Overview
- Dexcel Pharma Technologies Ltd. - Product and service
- Dexcel Pharma Technologies Ltd. - Key offerings
- Dexcel Pharma Technologies Ltd. - Key customers
- Dexcel Pharma Technologies Ltd. - Segment focus
- KAKEN PHARMACEUTICAL CO. LTD. - Overview
- KAKEN PHARMACEUTICAL CO. LTD. - Business segments
- KAKEN PHARMACEUTICAL CO. LTD. - Key offerings
- KAKEN PHARMACEUTICAL CO. LTD. - Key customers
- KAKEN PHARMACEUTICAL CO. LTD. - Segment focus
- Pfizer Inc. - Overview
- Pfizer Inc. - Business segments
- Pfizer Inc. - Key offerings
- Pfizer Inc. - Key customers
- Pfizer Inc. - Segment focus
- Straumann Holding AG - Overview
- Straumann Holding AG - Business segments
- Straumann Holding AG - Key offerings
- Straumann Holding AG - Key customers
- Straumann Holding AG - Segment focus
- Sunstar Suisse SA - Overview
- Sunstar Suisse SA - Business segments
- Sunstar Suisse SA - Key offerings
- Sunstar Suisse SA - Key customers
- Sunstar Suisse SA - Segment focus
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Key customers
- Teva Pharmaceutical Industries Ltd. - Segment focus
- Currency conversion rates for US$
- Research Methodology
- Validation techniques employed for market sizing
- Information sources
- List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global periodontal therapeutics market: 3M Co., Bausch Health Companies Inc., Cadila Healthcare Ltd., Den-Mat Holdings LLC, Dexcel Pharma Technologies Ltd., KAKEN PHARMACEUTICAL CO. LTD., Pfizer Inc., Straumann Holding AG, Sunstar Suisse SA, and Teva Pharmaceutical Industries Ltd.
Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is the growing geriatric population.`
According to the report, one of the major drivers for this market is the rising prevalence of periodontal diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3M Co.
- Bausch Health Companies Inc.
- Cadila Healthcare Ltd.
- Den-Mat Holdings LLC
- Dexcel Pharma Technologies Ltd.
- KAKEN PHARMACEUTICAL CO. LTD.
- Pfizer Inc.
- Straumann Holding AG
- Sunstar Suisse SA
- Teva Pharmaceutical Industries Ltd.
